Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Oct;63(10):3759–3764. doi: 10.1128/iai.63.10.3759-3764.1995

Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages.

A M Sarmento 1, R Appelberg 1
PMCID: PMC173528  PMID: 7558277

Abstract

We studied the ability of two Mycobacterium avium strains with different virulences to induce tumor necrosis factor alpha (TNF) synthesis by mouse resident peritoneal macrophages (RPM phi) in vitro in an experiment to look for a possible correlation between virulence and this TNF-inducing capacity. The low-virulence strain, 1983, induced significantly higher production of TNF by RPM phi than did the high-virulence strain, ATCC 25291. TNF neutralization during culture of infected RPM phi resulted in enhancement of growth of strain 1983 and had no effect on growth of strain ATCC 25291; TNF treatment of strain ATCC 25291-infected macrophages had no effect on mycobacterial growth. The extent of M. avium growth and the amount of TNF synthesis were independent of the presence of contaminating T cells or NK cells in the macrophage monolayers. Intraperitoneal administration of anti-TNF monoclonal antibodies to BALB/c mice infected intravenously with M. avium 1983 abrogated the elimination of the bacteria in the liver and caused a slight increase in bacterial growth in the spleen. Neutralization of TNF led to a minor increase in the proliferation of M. avium ATCC 25291 in the liver and spleen of BALB/c mice late in infection. Anti-TNF treatment did not affect the growth of the two M. avium strains in BALB/c.Bcgr (C.D2) mice, suggesting that restriction of M. avium strains to induce TNF production by macrophages may limit their ability to proliferate both in vitro and in vivo.

Full Text

The Full Text of this article is available as a PDF (228.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelberg R., Castro A. G., Pedrosa J., Silva R. A., Orme I. M., Minóprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun. 1994 Sep;62(9):3962–3971. doi: 10.1128/iai.62.9.3962-3971.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Appelberg R., Orme I. M. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology. 1993 Nov;80(3):352–359. [PMC free article] [PubMed] [Google Scholar]
  3. Appelberg R., Sarmento A., Castro A. G. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence. Clin Exp Immunol. 1995 Aug;101(2):308–313. doi: 10.1111/j.1365-2249.1995.tb08356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barnes P. F., Chatterjee D., Brennan P. J., Rea T. H., Modlin R. L. Tumor necrosis factor production in patients with leprosy. Infect Immun. 1992 Apr;60(4):1441–1446. doi: 10.1128/iai.60.4.1441-1446.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bermudez L. E., Wu M., Petrofsky M., Young L. S. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun. 1992 Oct;60(10):4245–4252. doi: 10.1128/iai.60.10.4245-4252.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bermudez L. E., Young L. S. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol. 1988 May 1;140(9):3006–3013. [PubMed] [Google Scholar]
  7. Blackwell J. M., Roach T. I., Atkinson S. E., Ajioka J. W., Barton C. H., Shaw M. A. Genetic regulation of macrophage priming/activation: the Lsh gene story. Immunol Lett. 1991 Oct;30(2):241–248. doi: 10.1016/0165-2478(91)90032-6. [DOI] [PubMed] [Google Scholar]
  8. Bonta I. L., Ben-Efraim S., Mózes T., Fieren M. W. Tumour necrosis factor in inflammation: relation to other mediators and to macrophage antitumour defence. Pharmacol Res. 1991 Aug;24(2):115–130. doi: 10.1016/1043-6618(91)90027-u. [DOI] [PubMed] [Google Scholar]
  9. Bradley D. J., Taylor B. A., Blackwell J., Evans E. P., Freeman J. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol. 1979 Jul;37(1):7–14. [PMC free article] [PubMed] [Google Scholar]
  10. Chatterjee D., Roberts A. D., Lowell K., Brennan P. J., Orme I. M. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun. 1992 Mar;60(3):1249–1253. doi: 10.1128/iai.60.3.1249-1253.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Denis M., Gregg E. O. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. Immunology. 1990 Sep;71(1):139–141. [PMC free article] [PubMed] [Google Scholar]
  12. Denis M. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J Leukoc Biol. 1991 Nov;50(5):495–501. doi: 10.1002/jlb.50.5.495. [DOI] [PubMed] [Google Scholar]
  13. Denis M. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria. Clin Exp Immunol. 1991 Mar;83(3):466–471. doi: 10.1111/j.1365-2249.1991.tb05662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fattorini L., Xiao Y., Li B., Santoro C., Ippoliti F., Orefici G. Induction of IL-1 beta, IL-6, TNF-alpha, GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium. J Med Microbiol. 1994 Feb;40(2):129–133. doi: 10.1099/00222615-40-2-129. [DOI] [PubMed] [Google Scholar]
  15. Flick D. A., Gifford G. E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984 Mar 30;68(1-2):167–175. doi: 10.1016/0022-1759(84)90147-9. [DOI] [PubMed] [Google Scholar]
  16. Furney S. K., Skinner P. S., Roberts A. D., Appelberg R., Orme I. M. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect Immun. 1992 Oct;60(10):4410–4413. doi: 10.1128/iai.60.10.4410-4413.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goto Y., Nakamura R. M., Takahashi H., Tokunaga T. Genetic control of resistance to Mycobacterium intracellulare infection in mice. Infect Immun. 1984 Oct;46(1):135–140. doi: 10.1128/iai.46.1.135-140.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gros P., Skamene E., Forget A. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J Immunol. 1983 Oct;131(4):1966–1972. [PubMed] [Google Scholar]
  19. Gros P., Skamene E., Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol. 1981 Dec;127(6):2417–2421. [PubMed] [Google Scholar]
  20. Inderlied C. B., Kemper C. A., Bermudez L. E. The Mycobacterium avium complex. Clin Microbiol Rev. 1993 Jul;6(3):266–310. doi: 10.1128/cmr.6.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kindler V., Sappino A. P., Grau G. E., Piguet P. F., Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989 Mar 10;56(5):731–740. doi: 10.1016/0092-8674(89)90676-4. [DOI] [PubMed] [Google Scholar]
  22. Koo G. C., Dumont F. J., Tutt M., Hackett J., Jr, Kumar V. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol. 1986 Dec 15;137(12):3742–3747. [PubMed] [Google Scholar]
  23. Langermans J. A., Van der Hulst M. E., Nibbering P. H., Hiemstra P. S., Fransen L., Van Furth R. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol. 1992 Jan 15;148(2):568–574. [PubMed] [Google Scholar]
  24. O'Brien A. D., Scher I., Formal S. B. Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infect Immun. 1979 Aug;25(2):513–520. doi: 10.1128/iai.25.2.513-520.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ohmori Y., Wyner L., Narumi S., Armstrong D., Stoler M., Hamilton T. A. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol. 1993 Mar;142(3):861–870. [PMC free article] [PubMed] [Google Scholar]
  26. Orme I. M., Stokes R. W., Collins F. M. Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun. 1986 Oct;54(1):56–62. doi: 10.1128/iai.54.1.56-62.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pedrosa J., Flórido M., Kunze Z. M., Castro A. G., Portaels F., McFadden J., Silva M. T., Appelberg R. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol. 1994 Nov;98(2):210–216. doi: 10.1111/j.1365-2249.1994.tb06127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pitchenik A. E., Fertel D. Medical management of AIDS patients. Tuberculosis and nontuberculous mycobacterial disease. Med Clin North Am. 1992 Jan;76(1):121–171. doi: 10.1016/s0025-7125(16)30375-3. [DOI] [PubMed] [Google Scholar]
  29. Plant J., Glynn A. A. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis. 1976 Jan;133(1):72–78. doi: 10.1093/infdis/133.1.72. [DOI] [PubMed] [Google Scholar]
  30. Pourshafie M., Ayub Q., Barrow W. W. Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells. Clin Exp Immunol. 1993 Jul;93(1):72–79. doi: 10.1111/j.1365-2249.1993.tb06499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rothe J., Lesslauer W., Lötscher H., Lang Y., Koebel P., Köntgen F., Althage A., Zinkernagel R., Steinmetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993 Aug 26;364(6440):798–802. doi: 10.1038/364798a0. [DOI] [PubMed] [Google Scholar]
  32. Tite J. P., Dougan G., Chatfield S. N. The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol. 1991 Nov 1;147(9):3161–3164. [PubMed] [Google Scholar]
  33. Tracey K. J., Cerami A. Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med. 1992 Jun;200(2):233–239. doi: 10.3181/00379727-200-43426. [DOI] [PubMed] [Google Scholar]
  34. Tracey K. J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317–343. doi: 10.1146/annurev.cb.09.110193.001533. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES